American Association of Clinical Endocrinology Consensus Statement: Comprehensive Type 2 Diabetes Management Algorithm-2023 Update

Article Medicine, General & Internal

Empagliflozin in Patients with Chronic Kidney Disease

William G. Herrington et al.

Summary: Empagliflozin therapy reduces the risk of disease progression or cardiovascular death in patients with chronic kidney disease.

NEW ENGLAND JOURNAL OF MEDICINE (2023)

添加到收藏夹

Article Cardiac & Cardiovascular Systems

Statin-Associated Muscle Symptoms Among New Statin Users Randomly Assigned to Vitamin D or Placebo

Mark A. Hlatky et al.

Summary: This study found that vitamin D supplementation did not prevent statin-associated muscle symptoms (SAMS) or reduce statin discontinuation, and the results were consistent across different pretreatment 25-hydroxy vitamin D levels.

JAMA CARDIOLOGY (2023)

添加到收藏夹

Article Endocrinology & Metabolism

American Association of Clinical Endocrinology Consensus Statement: Addressing Stigma and Bias in the Diagnosis and Management of Patients with Obesity/Adiposity-Based Chronic Disease and Assessing Bias and Stigmatization as Determinants of Disease Severity

Karl Nadolsky et al.

Summary: This study aims to explore the intersection of perception, diagnosis, stigma, and weight bias in the management of obesity and provide actionable steps to improve care for persons with obesity. The results suggest that improving the classification categories of obesity, assessing weight stigma and internalized bias, and increasing awareness and educational tools for healthcare professionals are necessary for optimal care.

ENDOCRINE PRACTICE (2023)

添加到收藏夹

Article Cardiac & Cardiovascular Systems

Cardiovascular and kidney outcomes with finerenone in patients with type 2 diabetes and chronic kidney disease: the FIDELITY pooled analysis

Rajiv Agarwal et al.

Summary: The study found that finerenone can reduce the risk of kidney disease and cardiovascular events in patients with type 2 diabetes. Screening patients for albuminuria can help reduce the burden of cardiovascular and kidney disease.

EUROPEAN HEART JOURNAL (2022)

添加到收藏夹

Article Endocrinology & Metabolism

DCRM Multispecialty Practice Recommendations for the management of diabetes, cardiorenal, and metabolic diseases

Yehuda Handelsman et al.

Summary: Type 2 diabetes, chronic kidney disease, atherosclerotic cardiovascular disease, and heart failure, along with their associated risk factors, have overlapping etiologies and frequently occur together in patients. Recent cardiovascular outcome trials have shown that drugs developed for controlling risk factors of these diseases can provide benefits in a range of conditions. Therefore, practice recommendations are needed to help clinicians manage patients with complex conditions involving diabetes, cardiorenal, and metabolic diseases.

JOURNAL OF DIABETES AND ITS COMPLICATIONS (2022)

添加到收藏夹

Article Medicine, General & Internal

Triglyceride Lowering with Pemafibrate to Reduce Cardiovascular Risk

Aruna Das Pradhan et al.

Summary: In patients with type 2 diabetes and high triglyceride levels, pemafibrate can reduce triglyceride, VLDL cholesterol, remnant cholesterol, and apolipoprotein C-III levels, but does not lower the incidence of cardiovascular events.

NEW ENGLAND JOURNAL OF MEDICINE (2022)

添加到收藏夹

Article Endocrinology & Metabolism

American Association of Clinical Endocrinology Clinical Practice Guideline: Developing a Diabetes Mellitus Comprehensive Care Plan-2022 Update

Lawrence Blonde et al.

Summary: This updated clinical practice guideline provides comprehensive evidence-based recommendations for the care of individuals with diabetes mellitus, aiming to improve the quality of care and assist clinical decision-making for healthcare professionals.

ENDOCRINE PRACTICE (2022)

添加到收藏夹

Editorial Material Endocrinology & Metabolism

What's preventing us from curbing the obesity crisis?

[Anonymous]

LANCET DIABETES & ENDOCRINOLOGY (2022)

添加到收藏夹

Article Endocrinology & Metabolism

Management of Hyperglycemia in Type 2 Diabetes, 2022. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)

Melanie J. Davies et al.

Summary: The American Diabetes Association and the European Association for the Study of Diabetes have updated the consensus statements on the management of hyperglycemia in adults with type 2 diabetes. The new recommendations highlight the importance of social determinants of health, weight management, and provide practical tips for implementation.

DIABETES CARE (2022)

添加到收藏夹

Article Medicine, General & Internal

Tirzepatide Once Weekly for the Treatment of Obesity

Ania M. Jastreboff et al.

Summary: In this 72-week trial in participants with obesity, once-weekly doses of 5 mg, 10 mg, or 15 mg of tirzepatide provided substantial and sustained reductions in body weight, and improvements in cardiometabolic measures were also observed.

NEW ENGLAND JOURNAL OF MEDICINE (2022)

添加到收藏夹

Correction Cardiac & Cardiovascular Systems

Cardiovascular and kidney outcomes with finerenone in patients with type 2 diabetes and chronic kidney disease: the FIDELITY pooled analysis (vol 43, pg 474, 2022)

Rajiv Agarwal et al.

EUROPEAN HEART JOURNAL (2022)

添加到收藏夹

Article Cardiac & Cardiovascular Systems

Cardiac and Kidney Benefits of Empagliflozin in Heart Failure Across the Spectrum of Kidney Function Insights From EMPEROR-Reduced

Faiez Zannad et al.

Summary: In the EMPEROR-Reduced trial, empagliflozin treatment had beneficial effects on key efficacy outcomes and slowed the rate of kidney function decline in patients with and without chronic kidney disease, regardless of the severity of kidney impairment at baseline.

CIRCULATION (2021)

添加到收藏夹

Article Cardiac & Cardiovascular Systems

Association of SGLT2 Inhibitors With Cardiovascular and Kidney Outcomes in Patients With Type 2 Diabetes A Meta-analysis

Darren K. McGuire et al.

Summary: SGLT2 inhibitors were found to reduce the risk of major adverse CV events and showed significant heterogeneity in associations with CV death. The most consistent benefit of this class of drugs was a reduction in risk for heart failure and kidney outcomes, with heart failure risk reduction being the most consistent observation across the trials.

JAMA CARDIOLOGY (2021)

添加到收藏夹

Article Endocrinology & Metabolism

Durability of Triple Combination Therapy Versus Stepwise Addition Therapy in Patients With New-Onset T2DM: 3-Year Follow-up of EDICT

Muhammad Abdul-Ghani et al.

Summary: The study found that initiating therapy with metformin/pioglitazone/exenatide (triple therapy) in patients with new-onset T2DM resulted in greater and more durable reduction in HbA(1c) compared to conventional therapy with metformin followed by glipizide and insulin. Triple therapy also significantly increased insulin sensitivity and beta-cell function, highlighting the importance of addressing underlying metabolic defects in T2DM treatment.

DIABETES CARE (2021)

添加到收藏夹

Article Endocrinology & Metabolism

COVID-19 Severity Is Tripled in the Diabetes Community: A Prospective Analysis of the Pandemic's Impact in Type 1 and Type 2 Diabetes

Justin M. Gregory et al.

Summary: The study found that patients with diabetes, both type 1 and type 2, have an increased risk of hospitalization and illness severity due to COVID-19. Factors such as HbA(1c) in type 1 diabetes were significantly associated with illness severity, emphasizing the need to mitigate the risk of severe acute respiratory syndrome coronavirus 2 infection in this community.

DIABETES CARE (2021)

添加到收藏夹

Review Endocrinology & Metabolism

Predictive value of abnormal ankle-brachial index in patients with diabetes: A meta-analysis

Fengze Nie et al.

Summary: This meta-analysis found that abnormal ankle brachial index (ABI) is associated with a higher risk of cardiovascular or all-cause mortality and major adverse cardiovascular events (MACEs) in patients with diabetes. The predictive role of abnormal ABI is largely dominated by the low ABI rather than the high ABI.

DIABETES RESEARCH AND CLINICAL PRACTICE (2021)

添加到收藏夹

Article Medicine, General & Internal

Effect of Subcutaneous Semaglutide vs Placebo as an Adjunct to Intensive Behavioral Therapy on Body Weight in Adults With Overweight or Obesity The STEP 3 Randomized Clinical Trial

Thomas A. Wadden et al.

Summary: This study compared the effects of once-weekly subcutaneous semaglutide with placebo as an adjunct to intensive behavioral therapy and initial low-calorie diet for weight management in adults with overweight or obesity. The results showed that semaglutide led to significantly greater weight loss compared to placebo over 68 weeks, with a higher proportion of participants achieving weight loss goals. More research is needed to evaluate the long-term effectiveness of this treatment.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2021)

添加到收藏夹

Article Medicine, General & Internal

Once-Weekly Semaglutide in Adults with Overweight or Obesity

John P. H. Wilding et al.

Summary: The study demonstrates that for individuals with obesity, once-weekly use of 2.4 mg semaglutide in combination with lifestyle intervention can lead to sustained and clinically relevant weight loss, with significant improvements in cardiometabolic risk factors and physical functioning reported by participants.

NEW ENGLAND JOURNAL OF MEDICINE (2021)

添加到收藏夹

Article Endocrinology & Metabolism

Effect of dapagliflozin on the rate of decline in kidney function in patients with chronic kidney disease with and without type 2 diabetes: a prespecified analysis from the DAPA-CKD trial

Hiddo J. L. Heerspink et al.

Summary: Dapagliflozin significantly slowed the long-term decline in eGFR in patients with chronic kidney disease compared to placebo. The difference in eGFR slope between dapagliflozin and placebo was more pronounced in patients with type 2 diabetes, higher HbA(1c), and higher UACR.

LANCET DIABETES & ENDOCRINOLOGY (2021)

添加到收藏夹

Review Endocrinology & Metabolism

Cardiovascular, mortality, and kidney outcomes with GLP-1 receptor agonists in patients with type 2 diabetes: a systematic review and meta-analysis of randomised trials

Naveed Sattar et al.

Summary: The meta-analysis showed that GLP-1 receptor agonists can reduce the risk of major adverse cardiovascular events, all-cause mortality, hospital admission for heart failure, and worsening kidney function in patients with type 2 diabetes, regardless of structural homology.

LANCET DIABETES & ENDOCRINOLOGY (2021)

添加到收藏夹

Article Medicine, General & Internal

Effect of Continued Weekly Subcutaneous Semaglutide vs Placebo on Weight Loss Maintenance in Adults With Overweight or Obesity The STEP 4 Randomized Clinical Trial

Domenica Rubino et al.

Summary: Continuing treatment with semaglutide resulted in greater weight loss maintenance and improvement in other physical indicators compared to switching to placebo over a 48-week period in adults with overweight or obesity. The study also found that gastrointestinal events were more common with continued semaglutide, but discontinuation rates were similar between the two groups.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2021)

添加到收藏夹

Article Endocrinology & Metabolism

Comparison of a ready-to-use liquid glucagon injection administered by autoinjector to glucagon emergency kit for the symptomatic relief of severe hypoglycemia: two randomized crossover non-inferiority studies

Mark P. Christiansen et al.

Summary: The ready-to-use GAI was shown to be non-inferior to GEK in treating severe hypoglycemia, with a similar tolerability profile. GAI is an effective, safe, and well-tolerated rescue treatment for severe hypoglycemia and is a viable alternative to GEK.

BMJ OPEN DIABETES RESEARCH & CARE (2021)

添加到收藏夹

Article Cardiac & Cardiovascular Systems

Apolipoprotein B and Non-HDL Cholesterol Better Reflect Residual Risk Than LDL Cholesterol in Statin-Treated Patients

Camilla Ditlev Lindhardt Johannesen et al.

Summary: Elevated levels of apoB and non-HDL cholesterol, but not LDL cholesterol, are associated with residual risk of all-cause mortality and myocardial infarction in statin-treated patients. Discordance analysis indicates that apoB is a more accurate marker of all-cause mortality risk and risk of myocardial infarction in these patients compared to LDL cholesterol.

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2021)

添加到收藏夹

Article Cardiac & Cardiovascular Systems

Usefulness of Glucagon-Like Peptide-1 Receptor Agonists to Reduce Adverse Cardiovascular Disease Events in Patients with Type 2 Diabetes Mellitus

Simran Grewal et al.

Summary: This study found that GLP-1 RA can reduce the risk of cardiovascular disease events in patients with type 2 diabetes, including major adverse cardiovascular events, cardiovascular death, and nonfatal stroke. However, the effect of GLP-1 RA on nonfatal myocardial infarction was not significant, and a linear relationship between baseline A1C and the impact of GLP-1 RA on nonfatal myocardial infarction was observed.

AMERICAN JOURNAL OF CARDIOLOGY (2021)

添加到收藏夹

Review Endocrinology & Metabolism

Strategies for overcoming therapeutic inertia in type 2 diabetes: A systematic review and meta-analysis

Rhea E. Powell et al.

Summary: The study demonstrated that interventions led by non-physician providers such as nurses, pharmacists, and diabetes educators were most effective in mitigating therapeutic inertia and improving HbA1c levels.

DIABETES OBESITY & METABOLISM (2021)

添加到收藏夹

Article Endocrinology & Metabolism

American Association of Clinical Endocrinology Clinical Practice Guideline: The Use of Advanced Technology in the Management of Persons With Diabetes Mellitus

George Grunberger et al.

Summary: This article summarizes the evidence-based recommendations of AACE on the use of advanced technology in the management of diabetes, including 37 clinical practice recommendations informed by 357 citations. The study highlights that advanced diabetes technology can improve self-management capabilities and quality of life for patients, as well as enhance the efficiency and effectiveness of clinical decision-making.

ENDOCRINE PRACTICE (2021)

添加到收藏夹

Article Medicine, General & Internal

Effect of Continuous Glucose Monitoring on Glycemic Control in Patients With Type 2 Diabetes Treated With Basal Insulin A Randomized Clinical Trial

Thomas Martens et al.

Summary: Continuous glucose monitoring (CGM) was more effective in reducing HbA1c levels at 8 months compared to blood glucose meter (BGM) monitoring in adults with poorly controlled type 2 diabetes treated with basal insulin without prandial insulin. Participants using CGM also showed better time in target glucose range and lower mean glucose values.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2021)

添加到收藏夹

Article Medicine, General & Internal

Association of Real-time Continuous Glucose Monitoring With Glycemic Control and Acute Metabolic Events Among Patients With Insulin-Treated Diabetes

Andrew J. Karter et al.

Summary: In this retrospective cohort study, insulin-treated patients with diabetes who were selected by physicians for real-time continuous glucose monitoring showed significant improvements in HbA1c and reductions in emergency department visits and hospitalizations for hypoglycemia compared to noninitiators, but there were no significant changes in emergency department visits or hospitalizations for hyperglycemia or for any reason.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2021)

添加到收藏夹

Article Medicine, General & Internal

Cardiovascular Events with Finerenone in Kidney Disease and Type 2 Diabetes

Bertram Pitt et al.

Summary: Finerenone therapy improved cardiovascular outcomes in patients with type 2 diabetes and stage 2 to 4 CKD with moderately elevated albuminuria or stage 1 or 2 CKD with severely elevated albuminuria, compared to placebo. The risk of the primary outcome event was significantly lower in the finerenone group, primarily driven by a reduction in hospitalization for heart failure.

NEW ENGLAND JOURNAL OF MEDICINE (2021)

添加到收藏夹

Article Multidisciplinary Sciences

Effects of SGLT2 inhibitors on stroke and its subtypes in patients with type 2 diabetes: a systematic review and meta-analysis

Wen-Hsuan Tsai et al.

Summary: The meta-analysis results showed that SGLT2 inhibitors have a neutral effect on the risk of stroke and its subtypes, but may have a potential protective effect against hemorrhagic stroke.

SCIENTIFIC REPORTS (2021)

添加到收藏夹

Article Medicine, General & Internal

Stroke Risk Factors in United States: An Analysis of the 2013-2018 National Health and Nutrition Examination Survey

Zhouming Ren et al.

Summary: Age, hypertension, dietary fiber consumption, and education level are significant risk factors for stroke among elders aged >60 years. Diabetes is the strongest predictor of stroke, while glycohemoglobin and plasma fasting glucose are also associated with stroke risks, emphasizing the importance of glycemic control in stroke prevention and management among older adults.

INTERNATIONAL JOURNAL OF GENERAL MEDICINE (2021)

添加到收藏夹

Article Endocrinology & Metabolism

Efficacy and safety of different basal and prandial insulin analogues for the treatment of type 2 diabetes: a network meta-analysis of randomized controlled trials

Edoardo Mannucci et al.

Summary: This study supports the use of long-acting analogues over NPH insulin as basal insulin for the treatment of type 2 diabetes, without showing preference for any individual long-acting analogue. Evidence on short-acting analogues is limited.

ENDOCRINE (2021)

添加到收藏夹

Article Public, Environmental & Occupational Health

Surveillance of Vaccination Coverage Among Adult Populations - United States, 2018

Peng-Jun Lu et al.

Summary: The translation highlights that many adults are at risk for illness and death from vaccine-preventable diseases. Despite the longstanding recommendations for vaccination, the coverage among U.S. adults remains low. The data indicate that substantial improvement in adult vaccination uptake is needed to reduce the burden of vaccine-preventable diseases.

MMWR SURVEILLANCE SUMMARIES (2021)

添加到收藏夹

Review Cardiac & Cardiovascular Systems

Association of lowering apolipoprotein B with cardiovascular outcomes across various lipid-lowering therapies: Systematic review and meta-analysis of trials

Safi U. Khan et al.

EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY (2020)

添加到收藏夹

Article Endocrinology & Metabolism

Comparison of lixisenatide in combination with basal insulin vs other insulin regimens for the treatment of patients with type 2 diabetes inadequately controlled by basal insulin: Systematic review, network meta-analysis and cost-effectiveness analysis

Peng Men et al.

DIABETES OBESITY & METABOLISM (2020)

添加到收藏夹

Article Cardiac & Cardiovascular Systems

Impaired fasting glucose and major adverse cardiovascular events by hypertension and dyslipidemia status: the Golestan cohort study

Nahid Hashemi Madani et al.

BMC CARDIOVASCULAR DISORDERS (2020)

添加到收藏夹

Article Urology & Nephrology

Safety of Liraglutide in Type 2 Diabetes and Chronic Kidney Disease

Johannes F. E. Mann et al.

CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2020)

添加到收藏夹

Article Endocrinology & Metabolism

CONSENSUS STATEMENT BY THE AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY ON THE COMPREHENSIVE TYPE 2 DIABETES MANAGEMENT ALGORITHM-2020 EXECUTIVE SUMMARY

Alan J. Garber et al.

ENDOCRINE PRACTICE (2020)

添加到收藏夹

Article Cardiac & Cardiovascular Systems

Association of small dense low-density lipoprotein with cardiovascular outcome in patients with coronary artery disease and diabetes: a prospective, observational cohort study

Jing-Lu Jin et al.

CARDIOVASCULAR DIABETOLOGY (2020)

添加到收藏夹

Article Cardiac & Cardiovascular Systems

2020 Expert Consensus Decision Pathway on Novel Therapies for Cardiovascular Risk Reduction in Patients With Type 2 Diabetes

Sandeep R. Das et al.

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2020)

添加到收藏夹

Article Medicine, General & Internal

Cardiovascular and Renal Outcomes with Empagliflozin in Heart Failure

Milton Packer et al.

NEW ENGLAND JOURNAL OF MEDICINE (2020)

添加到收藏夹

Article Medicine, General & Internal

Effect of Finerenone on Chronic Kidney Disease Outcomes in Type 2 Diabetes

George L. Bakris et al.

NEW ENGLAND JOURNAL OF MEDICINE (2020)

添加到收藏夹

Article Pharmacology & Pharmacy

Blood pressure control in type 2 diabetes mellitus with arterial hypertension. The important ancillary role of SGLT2-inhibitors and GLP1-receptor agonists

C. Berraa et al.

PHARMACOLOGICAL RESEARCH (2020)

添加到收藏夹

Review Cardiac & Cardiovascular Systems

Coronary Artery Calcification Under Statin Therapy and Its Effect on Cardiovascular Outcomes: A Systematic Review and Meta-Analysis

Runmin Lai et al.

FRONTIERS IN CARDIOVASCULAR MEDICINE (2020)

添加到收藏夹

Review Endocrinology & Metabolism

CONSENSUS STATEMENT BY THE AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY ON THE MANAGEMENT OF DYSLIPIDEMIA AND PREVENTION OF CARDIOVASCULAR DISEASE ALGORITHM-2020 EXECUTIVE SUMMARY

Yehuda Handelsman et al.

ENDOCRINE PRACTICE (2020)

添加到收藏夹

Article Endocrinology & Metabolism

Two-year-supervised resistance training prevented diabetes incidence in people with prediabetes: A randomised control trial

Xia Dai et al.

DIABETES-METABOLISM RESEARCH AND REVIEWS (2019)

添加到收藏夹

Article Endocrinology & Metabolism

CONSENSUS STATEMENT BY THE AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY ON THE COMPREHENSIVE TYPE 2 DIABETES MANAGEMENT ALGORITHM-2019 EXECUTIVE SUMMARY

Alan J. Garber et al.

ENDOCRINE PRACTICE (2019)

添加到收藏夹

Article Clinical Neurology

Pioglitazone Therapy in Patients With Stroke and Prediabetes A Post Hoc Analysis of the IRIS Randomized Clinical Trial

J. David Spence et al.

JAMA NEUROLOGY (2019)

添加到收藏夹

Article Medicine, General & Internal

Association of Nonfasting vs Fasting Lipid Levels With Risk of Major Coronary Events in the Anglo-Scandinavian Cardiac Outcomes Trial-Lipid Lowering Arm

Samia Mora et al.

JAMA INTERNAL MEDICINE (2019)

添加到收藏夹

Article Medicine, General & Internal

Glycaemic durability of an early combination therapy with vildagliptin and metformin versus sequential metformin monotherapy in newly diagnosed type 2 diabetes (VERIFY): a 5-year, multicentre, randomised, double-blind trial

David R. Matthews et al.

LANCET (2019)

添加到收藏夹

Review Medicine, General & Internal

Benefits and harms of intensive glycemic control in patients with type 2 diabetes

Rene Rodriguez-Gutierrez et al.

BMJ-BRITISH MEDICAL JOURNAL (2019)

添加到收藏夹

Article Hematology

Statin Safety and Associated Adverse Events: A Scientific Statement From the American Heart Association

Connie B. Newman et al.

ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2019)

添加到收藏夹

Review Cardiac & Cardiovascular Systems

Apolipoprotein B Particles and Cardiovascular Disease A Narrative Review

Allan D. Sniderman et al.

JAMA CARDIOLOGY (2019)

添加到收藏夹

Article Endocrinology & Metabolism

Adverse differences in cardiometabolic risk factor levels between individuals with pre-diabetes and normal glucose metabolism are more pronounced in women than in men: the Maastricht Study

Rianneke de Ritter et al.

BMJ OPEN DIABETES RESEARCH & CARE (2019)

添加到收藏夹

Article Endocrinology & Metabolism

The Relationship of Hemoglobin A1C to Time-in-Range in Patients with Diabetes

Robert A. Vigersky et al.

DIABETES TECHNOLOGY & THERAPEUTICS (2019)

添加到收藏夹

Article Medicine, General & Internal

Cardiovascular Risk Reduction with Icosapent Ethyl for Hypertriglyceridemia

Deepak L. Bhatt et al.

NEW ENGLAND JOURNAL OF MEDICINE (2019)

添加到收藏夹

Article Endocrinology & Metabolism

A Randomized, Double-Blind, Placebo-Controlled Study of Gelesis100: A Novel Nonsystemic Oral Hydrogel for Weight Loss

Frank L. Greenway et al.

OBESITY (2019)

添加到收藏夹

Article Endocrinology & Metabolism

Intensive LDL cholesterol-lowering treatment beyond current recommendations for the prevention of major vascular events: a systematic review and meta-analysis of randomised trials including 327 037 participants

Nelson Wang et al.

Lancet Diabetes & Endocrinology (2019)

添加到收藏夹

Article Cardiac & Cardiovascular Systems

Impact of Novel Low-Density Lipoprotein-Cholesterol Assessment on the Utility of Secondary Non-High-Density Lipoprotein-C and Apolipoprotein B Targets in Selected Worldwide Dyslipidemia Guidelines

Vasanth Sathiyakumar et al.

CIRCULATION (2018)

添加到收藏夹

Review Endocrinology & Metabolism

CONSENSUS STATEMENT BY THE AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY ON THE COMPREHENSIVE TYPE 2 DIABETES MANAGEMENT ALGORITHM-2018 EXECUTIVE SUMMARY

Alan J. Garber et al.

ENDOCRINE PRACTICE (2018)

添加到收藏夹

Review Endocrinology & Metabolism

Diagnosis and management of primary aldosteronism: the Endocrine Society guideline 2016 revisited

Tracy Ann Williams et al.

EUROPEAN JOURNAL OF ENDOCRINOLOGY (2018)

添加到收藏夹

Article Peripheral Vascular Disease

Impacts of Prediabetes Mellitus Alone or Plus Hypertension on the Coronary Severity and Cardiovascular Outcomes

Hui-Hui Liu et al.

HYPERTENSION (2018)

添加到收藏夹

Review Biotechnology & Applied Microbiology

Immunogenicity, safety, and effectiveness of seasonal influenza vaccination in patients with diabetes mellitus: A systematic review

Gael Dos Santos et al.

HUMAN VACCINES & IMMUNOTHERAPEUTICS (2018)

添加到收藏夹

Correction Endocrinology & Metabolism

Reduction in the Incidence of Type 2 Diabetes With the Mediterranean Diet: Results of the PREDIMED-Reus nutrition intervention randomized trial (vol 34, pg 14, 2011)

Jordi Salas-Salvado et al.

DIABETES CARE (2018)

添加到收藏夹

Editorial Material Endocrinology & Metabolism

Glucose Management Indicator (GMI): A New Term for Estimating A1C From Continuous Glucose Monitoring

Richard M. Bergenstal et al.

DIABETES CARE (2018)

添加到收藏夹

Article Cardiac & Cardiovascular Systems

Effects of Liraglutide Versus Placebo on Cardiovascular Events in Patients With Type 2 Diabetes Mellitus and Chronic Kidney Disease Results From the LEADER Trial

Johannes F. E. Mann et al.

CIRCULATION (2018)

添加到收藏夹

Article Peripheral Vascular Disease

Resistant Hypertension: Detection, Evaluation, and Management: A Scientific Statement From the American Heart Association

Robert M. Carey et al.

HYPERTENSION (2018)

添加到收藏夹

Article Urology & Nephrology

The Long-Term Impact of Renin-Angiotensin System (RAS) Inhibition on Cardiorenal Outcomes (LIRICO): A Randomized, Controlled Trial

Valeria Saglimbene et al.

JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2018)

添加到收藏夹

Article Endocrinology & Metabolism

Pharmacokinetic and Pharmacodynamic Characteristics of Dasiglucagon, a Novel Soluble and Stable Glucagon Analog

Ulrike Hoevelmann et al.

DIABETES CARE (2018)

添加到收藏夹

Review Endocrinology & Metabolism

Therapeutic inertia in the treatment of hyperglycaemia in patients with type 2 diabetes: A systematic review

Kamlesh Khunti et al.

DIABETES OBESITY & METABOLISM (2018)

添加到收藏夹

Review Emergency Medicine

Dietary sugars versus glucose tablets for first-aid treatment of symptomatic hypoglycaemia in awake patients with diabetes: a systematic review and meta-analysis

Jestin N. Carlson et al.

EMERGENCY MEDICINE JOURNAL (2017)

添加到收藏夹

Review Clinical Neurology

Pioglitazone for Secondary Stroke Prevention: A Systematic Review and Meta-Analysis

Meng Lee et al.

STROKE (2017)

添加到收藏夹

Article Endocrinology & Metabolism

Flash Glucose-Sensing Technology as a Replacement for Blood Glucose Monitoring for the Management of Insulin-Treated Type 2 Diabetes: a Multicenter, Open-Label Randomized Controlled Trial

Thomas Haak et al.

DIABETES THERAPY (2017)

添加到收藏夹

Article Endocrinology & Metabolism

Flash Glucose-Sensing Technology as a Replacement for Blood Glucose Monitoring for the Management of Insulin-Treated Type 2 Diabetes: a Multicenter, Open-Label Randomized Controlled Trial

Thomas Haak et al.

DIABETES THERAPY (2017)

添加到收藏夹

Article Endocrinology & Metabolism

Updated risk factors should be used to predict development of diabetes

Mary Angelyn Bethel et al.

JOURNAL OF DIABETES AND ITS COMPLICATIONS (2017)

添加到收藏夹

Article Medicine, General & Internal

3 years of liraglutide versus placebo for type 2 diabetes risk reduction and weight management in individuals with prediabetes: a randomised, double-blind trial

Carel W. le Roux et al.

LANCET (2017)

添加到收藏夹

Article Medicine, General & Internal

Canagliflozin and Cardiovascular and Renal Events in Type 2 Diabetes

Bruce Neal et al.

NEW ENGLAND JOURNAL OF MEDICINE (2017)

添加到收藏夹

Article Endocrinology & Metabolism

Effects of acarbose on cardiovascular and diabetes outcomes in patients with coronary heart disease and impaired glucose tolerance (ACE): a randomised, double-blind, placebo-controlled trial

Rury R. Holman et al.

LANCET DIABETES & ENDOCRINOLOGY (2017)

添加到收藏夹

Article Cardiac & Cardiovascular Systems

Prevalence and treatment of atherogenic dyslipidemia in the primary prevention of cardiovascular disease in Europe: EURIKA, a cross-sectional observational study

Julian P. Halcox et al.

BMC CARDIOVASCULAR DISORDERS (2017)

添加到收藏夹

Article Nutrition & Dietetics

A Mediterranean diet lowers blood pressure and improves endothelial function: results from the MedLey randomized intervention trial

Courtney R. Davis et al.

AMERICAN JOURNAL OF CLINICAL NUTRITION (2017)

添加到收藏夹

Article Cardiac & Cardiovascular Systems

Cardiac Outcomes After Ischemic Stroke or Transient Ischemic Attack Effects of Pioglitazone in Patients With Insulin Resistance Without Diabetes Mellitus

Lawrence H. Young et al.

CIRCULATION (2017)

添加到收藏夹

Article Endocrinology & Metabolism

ADIPOSITY-BASED CHRONIC DISEASE AS A NEW DIAGNOSTIC TERM: THE AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY POSITION STATEMENT

Jeffrey I. Mechanick et al.

ENDOCRINE PRACTICE (2017)

添加到收藏夹

Article Endocrinology & Metabolism

AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY GUIDELINES FOR MANAGEMENT OF DYSLIPIDEMIA AND PREVENTION OF CARDIOVASCULAR DISEASE

Paul S. Jellinger et al.

ENDOCRINE PRACTICE (2017)

添加到收藏夹

Article Endocrinology & Metabolism

Intranasal Glucagon for Treatment of Insulin-Induced Hypoglycemia in Adults With Type 1 Diabetes: A Randomized Crossover Noninferiority Study

Michael R. Rickels et al.

DIABETES CARE (2016)

添加到收藏夹

Article Cardiac & Cardiovascular Systems

Warranty Period of Zero Coronary Artery Calcium Score for Predicting All-Cause Mortality According to Cardiac Risk Burden in Asymptomatic Korean Adults

Ji Hyun Lee et al.

CIRCULATION JOURNAL (2016)

添加到收藏夹

Article Cardiac & Cardiovascular Systems

Age, Gender, and Race-Based Coronary Artery Calcium Score Percentiles in the Brazilian Longitudinal Study of Adult Health (ELSA-Brasil)

Alexandre C. Pereira et al.

CLINICAL CARDIOLOGY (2016)

添加到收藏夹

Article Endocrinology & Metabolism

Glucagon Nasal Powder: A Promising Alternative to Intramuscular Glucagon in Youth With Type 1 Diabetes

Jennifer L. Sherr et al.

DIABETES CARE (2016)

添加到收藏夹

Article Endocrinology & Metabolism

CONSENSUS STATEMENT BY THE AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY ON THE COMPREHENSIVE TYPE 2 DIABETES MANAGEMENT ALGORITHM-2016 EXECUTIVE SUMMARY

Alan J. Garber et al.

ENDOCRINE PRACTICE (2016)

添加到收藏夹

Article Medicine, General & Internal

Antisense oligonucleotides targeting apolipoprotein(a) in people with raised lipoprotein(a): two randomised, double-blind, placebo-controlled, dose-ranging trials

Nicholas J. Viney et al.

LANCET (2016)

添加到收藏夹

Review Endocrinology & Metabolism

Bias in the measure of the effectiveness of seasonal influenza vaccination among diabetics

Ludouic Casanova et al.

PRIMARY CARE DIABETES (2016)

添加到收藏夹

Article Endocrinology & Metabolism

BeAM value: an indicator of the need to initiate and intensify prandial therapy in patients with type 2 diabetes mellitus receiving basal insulin

Ariel Zisman et al.

BMJ OPEN DIABETES RESEARCH & CARE (2016)

添加到收藏夹

Article Cardiac & Cardiovascular Systems

Traditional cardiovascular disease risk factors associated with one-year all-cause mortality among those with coronary artery calcium scores ≥400

Mahmoud Al Rifai et al.

ATHEROSCLEROSIS (2015)

添加到收藏夹

Article Endocrinology & Metabolism

Intensifying insulin regimen after basal insulin optimization in adults with type 2 diabetes: a 24-week, randomized, open-label trial comparing insulin glargine plus insulin glulisine with biphasic insulin aspart (LanScape)

J. Vora et al.

DIABETES OBESITY & METABOLISM (2015)

添加到收藏夹

Review Endocrinology & Metabolism

Impact of GLP-1 receptor agonists on blood pressure, heart rate and hypertension among patients with type 2 diabetes: A systematic review and network meta-analysis

Feng Sun et al.

DIABETES RESEARCH AND CLINICAL PRACTICE (2015)

添加到收藏夹

Article Endocrinology & Metabolism

CONSENSUS STATEMENT BY THE AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY ON THE COMPREHENSIVE TYPE 2 DIABETES MANAGEMENT ALGORITHM-2015 EXECUTIVE SUMMARY

Alan J. Garber et al.

ENDOCRINE PRACTICE (2015)

添加到收藏夹

Article Endocrinology & Metabolism

Prevalence of chronic kidney disease among individuals with diabetes in the SUPREME-DM Project, 2005-2011

Emily B. Schroeder et al.

JOURNAL OF DIABETES AND ITS COMPLICATIONS (2015)

添加到收藏夹

Article Medicine, General & Internal

Heart failure and mortality outcomes in patients with type 2 diabetes taking alogliptin versus placebo in EXAMINE: a multicentre, randomised, double-blind trial

Faiez Zannad et al.

LANCET (2015)

添加到收藏夹

Article Medicine, General & Internal

Comparative efficacy and safety of blood pressure-lowering agents in adults with diabetes and kidney disease: a network meta-analysis

Suetonia C. Palmer et al.

LANCET (2015)

添加到收藏夹

Article Medicine, General & Internal

Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes

Bernard Zinman et al.

NEW ENGLAND JOURNAL OF MEDICINE (2015)

添加到收藏夹

Article Psychiatry

The WHO-5 Well-Being Index: A Systematic Review of the Literature

Christian Winther Topp et al.

PSYCHOTHERAPY AND PSYCHOSOMATICS (2015)

添加到收藏夹

Article Surgery

The REDUCE pivotal trial: a prospective, randomized controlled pivotal trial of a dual intragastric balloon for the treatment of obesity

Jaime Ponce et al.

SURGERY FOR OBESITY AND RELATED DISEASES (2015)

添加到收藏夹

Article Endocrinology & Metabolism

AACE Comprehensive Diabetes Management Algorithm 2013

Alan Garber et al.

Endocrine Practice (2015)

添加到收藏夹

Correction Cardiac & Cardiovascular Systems

2013 ACC/AHA Guideline on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk in Adults: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (vol 63, pg 2889, 2014)

N. J. Stone et al.

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2015)

添加到收藏夹

Article Medicine, General & Internal

Prevention of Diabetes With Mediterranean Diets A Subgroup Analysis of a Randomized Trial

Jordi Salas-Salvado et al.

ANNALS OF INTERNAL MEDICINE (2014)

添加到收藏夹

Article Medicine, General & Internal

US Physicians' Perspective of Adult Vaccine Delivery

Laura P. Hurley et al.

ANNALS OF INTERNAL MEDICINE (2014)

添加到收藏夹

Article Endocrinology & Metabolism

Prevention of Type 2 Diabetes in Subjects With Prediabetes and Metabolic Syndrome Treated With Phentermine and Topiramate Extended Release

W. Timothy Garvey et al.

DIABETES CARE (2014)

添加到收藏夹

Review Nutrition & Dietetics

Efficacy of interventions that include diet, aerobic and resistance training components for type 2 diabetes prevention: a systematic review with meta-analysis

Elroy J. Aguiar et al.

INTERNATIONAL JOURNAL OF BEHAVIORAL NUTRITION AND PHYSICAL ACTIVITY (2014)

添加到收藏夹

Article Cardiac & Cardiovascular Systems

2013 AHA/ACC Guideline on Lifestyle Management to Reduce Cardiovascular Risk A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines

Robert H. Eckel et al.

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2014)

添加到收藏夹

Article Cardiac & Cardiovascular Systems

2013 ACC/AHA Guideline on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk in Adults A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines

Neil J. Stone et al.

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2014)

添加到收藏夹

Article Peripheral Vascular Disease

Effects of sodium-glucose co-transporter 2 inhibitors on blood pressure: A systematic review and meta-analysis

William L. Baker et al.

JOURNAL OF THE AMERICAN SOCIETY OF HYPERTENSION (2014)

添加到收藏夹

Article Surgery

Weight loss and improved quality of life with a nonsurgical endoscopic treatment for obesity: clinical results from a 3-and 6-month study

George Marinos et al.

SURGERY FOR OBESITY AND RELATED DISEASES (2014)

添加到收藏夹

Article Cardiac & Cardiovascular Systems

Prevalence and clinical outcomes of undiagnosed diabetes mellitus and prediabetes among patients with high-risk non-ST-segment elevation acute coronary syndrome

Roberto R. Giraldez et al.

AMERICAN HEART JOURNAL (2013)

添加到收藏夹

Article Medicine, General & Internal

Combined Angiotensin Inhibition for the Treatment of Diabetic Nephropathy

Linda F. Fried et al.

NEW ENGLAND JOURNAL OF MEDICINE (2013)

添加到收藏夹

Article Medicine, General & Internal

Saxagliptin and Cardiovascular Outcomes in Patients with Type 2 Diabetes Mellitus

Benjamin M. Scirica et al.

NEW ENGLAND JOURNAL OF MEDICINE (2013)

添加到收藏夹

Article Endocrinology & Metabolism

Short-term intensive insulin therapy in type 2 diabetes mellitus: a systematic review and meta-analysis

Caroline Kaercher Kramer et al.

LANCET DIABETES & ENDOCRINOLOGY (2013)

添加到收藏夹

Article Cardiac & Cardiovascular Systems

Efficacy of fibrates for cardiovascular risk reduction in persons with atherogenic dyslipidemia: A meta-analysis

Meng Lee et al.

ATHEROSCLEROSIS (2011)

添加到收藏夹

Article Cardiac & Cardiovascular Systems

Seven-year mortality in heart failure patients with undiagnosed diabetes: an observational study

Juana A. Flores-Le Roux et al.

CARDIOVASCULAR DIABETOLOGY (2011)

添加到收藏夹

Article Cardiac & Cardiovascular Systems

A Meta-Analysis of Low-Density Lipoprotein Cholesterol, Non-High-Density Lipoprotein Cholesterol, and Apolipoprotein B as Markers of Cardiovascular Risk

Allan D. Sniderman et al.

CIRCULATION-CARDIOVASCULAR QUALITY AND OUTCOMES (2011)

添加到收藏夹

Article Endocrinology & Metabolism

Benefits of Modest Weight Loss in Improving Cardiovascular Risk Factors in Overweight and Obese Individuals With Type 2 Diabetes

Rena R. Wing et al.

DIABETES CARE (2011)

添加到收藏夹

Article Endocrinology & Metabolism

Effects of initiation and titration of a single pre-prandial dose of insulin glulisine while continuing titrated insulin glargine in type 2 diabetes: a 6-month 'proof-of-concept' study

D. R. Owens et al.

DIABETES OBESITY & METABOLISM (2011)

添加到收藏夹

Review Medicine, General & Internal

Risk of Incident Diabetes With Intensive-Dose Compared With Moderate-Dose Statin Therapy A Meta-analysis

David Preiss et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2011)

添加到收藏夹

Review Cardiac & Cardiovascular Systems

Fibrates Effect on Cardiovascular Risk Is Greater in Patients With High Triglyceride Levels or Atherogenic Dyslipidemia Profile: A Systematic Review and Meta-analysis

Eric Bruckert et al.

JOURNAL OF CARDIOVASCULAR PHARMACOLOGY (2011)

添加到收藏夹

Article Medicine, General & Internal

Pioglitazone for Diabetes Prevention in Impaired Glucose Tolerance

Ralph A. DeFronzo et al.

NEW ENGLAND JOURNAL OF MEDICINE (2011)

添加到收藏夹

Article Endocrinology & Metabolism

Exercise and Type 2 Diabetes The American College of Sports Medicine and the American Diabetes Association joint position statement executive summary

Sheri R. Colberg et al.

DIABETES CARE (2010)

添加到收藏夹

Article Endocrinology & Metabolism

Exercise and Type 2 Diabetes: The American College of Sports Medicine and the American Diabetes Association: joint position statement

S. R. Colberg et al.

DIABETES CARE (2010)

添加到收藏夹

Article Medicine, General & Internal

Statins and risk of incident diabetes: a collaborative meta-analysis of randomised statin trials

Naveed Sattar et al.

LANCET (2010)

添加到收藏夹

Article Medicine, General & Internal

Effect of intensive treatment of hyperglycaemia on microvascular outcomes in type 2 diabetes: an analysis of the ACCORD randomised trial

Faramarz Ismail-Beigi et al.

LANCET (2010)

添加到收藏夹

Article Endocrinology & Metabolism

Effects of Fenofibrate Treatment on Cardiovascular Disease Risk in 9,795 Individuals With Type 2 Diabetes and Various Components of the Metabolic Syndrome The Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) study

Russell Scott et al.

DIABETES CARE (2009)

添加到收藏夹

Article Endocrinology & Metabolism

STATEMENT BY AN AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS/AMERICAN COLLEGE OF ENDOCRINOLOGY CONSENSUS PANEL ON TYPE 2 DIABETES MELLITUS: AN ALGORITHM FOR GLYCEMIC CONTROL

Helena W. Rodbard et al.

ENDOCRINE PRACTICE (2009)

添加到收藏夹

Article Peripheral Vascular Disease

Trends in blood pressure control and treatment among type 2 diabetes with comorbid hypertension in the United States: 1988–2004

Dong-Churl Suh et al.

JOURNAL OF HYPERTENSION (2009)

添加到收藏夹

Article Medicine, General & Internal

Glucose Control and Vascular Complications in Veterans with Type 2 Diabetes

William Duckworth et al.

NEW ENGLAND JOURNAL OF MEDICINE (2009)

添加到收藏夹

Article Medicine, General & Internal

Barriers to adult immunization

David R. Johnson et al.

AMERICAN JOURNAL OF MEDICINE (2008)

添加到收藏夹

Article Anesthesiology

STOP questionnaire - A tool to screen patients for obstructive sleep apnea

Frances Chung et al.

ANESTHESIOLOGY (2008)

添加到收藏夹

Article Cardiac & Cardiovascular Systems

C-Reactive Protein and Parental History Improve Global Cardiovascular Risk Prediction The Reynolds Risk Score for Men

Paul M. Ridker et al.

CIRCULATION (2008)

添加到收藏夹

Article Endocrinology & Metabolism

Introducing a simplified approach to insulin therapy in type 2 diabetes: a comparison of two single-dose regimens of insulin glulisine plus insulin glargine and oral antidiabetic drugs

M. R. Lankisch et al.

DIABETES OBESITY & METABOLISM (2008)

添加到收藏夹

Article Cardiac & Cardiovascular Systems

Lipoprotein management in patients with cardiometabolic risk - Consensus conference report from the American diabetes association and the American college of cardiology foundation

John D. Brunzell et al.

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2008)

添加到收藏夹

Article Medicine, General & Internal

Telmisartan, ramipril, or both in patients at high risk for vascular events

Salim Yusuf et al.

NEW ENGLAND JOURNAL OF MEDICINE (2008)

添加到收藏夹

Article Medicine, General & Internal

Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes

Anushka Patel et al.

NEW ENGLAND JOURNAL OF MEDICINE (2008)

添加到收藏夹

Article Endocrinology & Metabolism

Initiate insulin by aggressive titration and education (INITIATE) - A randomized study to compare initiation of insulin combination therapy in type 2 diabetic patients individually and in groups

Hannele Yki-Jarvinen et al.

DIABETES CARE (2007)

添加到收藏夹

Article Surgery

BioEnterics Intragastric Balloon: The Italian experience with 2,515 patients

A Genco et al.

OBESITY SURGERY (2005)

添加到收藏夹

Article Medicine, General & Internal

Renal outcomes in high-risk hypertensive patients treated with an angiotensin-converting enzyme inhibitor or a calcium channel blocker vs a diuretic - A report from the antihypertensive and lipid-lowering treatment to prevent heart attack trial (ALLHAT)

M Rahman et al.

ARCHIVES OF INTERNAL MEDICINE (2005)

添加到收藏夹

Article Endocrinology & Metabolism

Physical activity in the prevention of type 2 diabetes - The Finnish Diabetes Prevention Study

DE Laaksonen et al.

DIABETES (2005)

添加到收藏夹

Article Medicine, General & Internal

Association of hemoglobin A1c with cardiovascular disease and mortality in adults:: The European prospective investigation into cancer in Norfolk

KT Khaw et al.

ANNALS OF INTERNAL MEDICINE (2004)

添加到收藏夹

Article Medicine, General & Internal

Acarbose treatment and the risk of cardiovascular disease and hypertension in patients with impaired glucose tolerance - The STOP-NIDDM Ttrial

JL Chiasson et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2003)

添加到收藏夹

Article Endocrinology & Metabolism

Diabetic dyslipidaemia: from basic research to clinical practice

MR Taskinen

DIABETOLOGIA (2003)

添加到收藏夹

Article Cardiac & Cardiovascular Systems

Concordance/discordance between plasma apolipoprotein B levels and the cholesterol indexes of atherosclerotic risk

AD Sniderman et al.

AMERICAN JOURNAL OF CARDIOLOGY (2003)

添加到收藏夹

Article Peripheral Vascular Disease

Influence of weight reduction on blood pressure - A meta-analysis of randomized controlled trials

JE Neter et al.

HYPERTENSION (2003)

添加到收藏夹

Article Endocrinology & Metabolism

The treat-to-target trial - Randomized addition of glargine or human NPH insulin to oral therapy of type 2 diabetic patients

MC Riddle et al.

DIABETES CARE (2003)

添加到收藏夹

Article Cardiac & Cardiovascular Systems

Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) Final Report

SM Grundy et al.

CIRCULATION (2002)

添加到收藏夹

Article Medicine, General & Internal

The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men

HM Lakka et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2002)

添加到收藏夹

Article Public, Environmental & Occupational Health

Metabolic syndrome and development of diabetes mellitus: Application and validation of recently suggested definitions of the metabolic syndrome in a prospective cohort study

DE Laaksonen et al.

AMERICAN JOURNAL OF EPIDEMIOLOGY (2002)

添加到收藏夹

Article Medicine, General & Internal

Glucose metabolism in patients with acute myocardial infarction and no previous diagnosis of diabetes mellitus:: a prospective study

A Norhammar et al.

LANCET (2002)

添加到收藏夹

Article Medicine, General & Internal

Acarbose for prevention of type 2 diabetes mellitus: the STOPNIDDM randomised trial

JL Chiasson et al.

LANCET (2002)

添加到收藏夹

Article Medicine, General & Internal

Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin

WC Knowler et al.

NEW ENGLAND JOURNAL OF MEDICINE (2002)

添加到收藏夹

Article Health Care Sciences & Services

The PHQ-9 - Validity of a brief depression severity measure

K Kroenke et al.

JOURNAL OF GENERAL INTERNAL MEDICINE (2001)

添加到收藏夹

Article Medicine, General & Internal

Relation of impaired fasting and postload glucose with incident type 2 diabetes in a Dutch population - The Hoorn study

F de Vegt et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2001)

添加到收藏夹

Article Peripheral Vascular Disease

β-Adrenergic receptor blockers and weight gain -: A systematic analysis

AM Sharma et al.

HYPERTENSION (2001)

添加到收藏夹

Article Medicine, General & Internal

Effects on blood pressure of reduced dietary sodium and the dietary approaches to stop hypertension (DASH) diet.

FM Sacks et al.

NEW ENGLAND JOURNAL OF MEDICINE (2001)

添加到收藏夹

Article Medicine, General & Internal

Association of systolic blood pressure with macrovascular and microvascular complications of type 2 diabetes (UKPDS 36): prospective observational study

AI Adler et al.

BMJ-BRITISH MEDICAL JOURNAL (2000)

添加到收藏夹

Review Endocrinology & Metabolism

Use of influenza and pneumococcal vaccines in people with diabetes

SA Smith et al.

DIABETES CARE (2000)

添加到收藏夹

American Association of Clinical Endocrinology Consensus Statement: Comprehensive Type 2 Diabetes Management Algorithm-2023 Update

相关参考文献